ProMIS Neurosciences:募资所得预计将助力完成具有里程碑意义的1b期阿尔茨海默病研究,并支持关键临床里程碑的推进

美股速递
Jan 30

ProMIS Neurosciences Inc (PMN) 近日宣布,其通过融资所获得的资金预计将为公司完成其具有里程碑意义的1b期阿尔茨海默病(AD)研究提供关键支持。这笔资金还将用于推动公司实现其他重要的临床开发里程碑,为公司后续的临床进展和管线发展奠定坚实基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10